Categories: NewsNutrition

Smart for Life Announces Appointment of Jessica Walters as Chief Marketing Officer

CMO Expected to Position Smart for Life for Long Term Growth and Utilize IP from Acquisitions to Increase Sales Opportunities

MIAMI, July 09, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced that it has appointed Jessica Walters as the Company’s new Chief Marketing Officer. Ms. Walter’s appointment as CMO is believed by management to position Smart for Life for long term growth and utilize the Company’s IP from its acquisitions to increase sales opportunities across its portfolio.

“Our appointment of Jessica Walters as CMO represents a strategic effort to broaden our reach and strengthen our position in the Health and Wellness industry,” stated Darren Minton, CEO of Smart for Life. “Ms. Walters is a highly seasoned digital marketing executive who has provided comprehensive consulting services for a broad range of companies in various industries prior to her appointment. Her mandate at Smart for Life includes utilizing the core IP from our acquisitions and various marketing platforms to enhance our sales capabilities.”

A.J. Cervantes, Jr., Chairman added, “The team at Smart for Life has been hard at work re-purposing the IP from our marketing platforms for use with our various operating subsidiaries. Under Ms. Walter’s leadership, this IP is expected to be further expanded to include a roll-out positioned for our future acquisition targets, in addition to offering the marketing service to our contract manufacturing clients as well.”

Ms. Walters brings to Smart for Life a proven expertise in lead generation, conversion, database management and affiliate marketing expertise. With strong entrepreneurial skills and as a former Shark Tank contestant, Ms. Walters is able to quickly identify opportunities, assess market demand, and inform strategic data-driven decision making. She has guided companies such as Equinox, LIV Golf, Platinum Nightlife and Unstoppable Caching in developing and maintaining strong brands. Ms. Walters has established herself at the forefront of driving innovation in multiple industries, blending her experience in traditional sales with cutting-edge applications of affiliate marketing in branding, marketing and sales strategies.

“My focus at Smart for Life is bringing the overall marketing initiatives to Fortune 500 standards, with the ultimate goal of helping the Company achieve its stated objective of reaching $100 million in revenue by complimenting their M&A strategy in the nutraceutical space,” stated Ms. Walters, Smart for Life’s new Chief Marketing Officer. “I am excited to leverage not only my relevant experience and background across numerous industries, but also the Company’s core IP to enhance the sales channels at Smart for Life and drive the future affiliate marketing initiatives across all levels of the organization.”

For media inquiries or to schedule interviews with Smart for Life representatives, please contact: media@smartforlifecorp.com.

About Smart for Life, Inc.

Smart for Life, Inc. (Nasdaq: SMFL) is an emerging growth company in the nutraceutical industry, committed to delivering innovative solutions that promote Health & Wellness. With a focus on research-driven formulations and consumer-centric approaches, Smart for Life is dedicated to redefining the boundaries of nutritional science. The Company is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and products. Structured as a publicly held holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company. To drive growth and earnings, Smart for Life is developing proprietary and related products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company recently concluded the execution of a restructuring plan including recapitalization of the Company with equity and debt financings, the sale of certain non-performing assets, the sale and leaseback of the Company’s 18,000 sq. ft. Doral manufacturing facility and the successful liquidation of the Company’s senior debt facility. In addition, the Company converted substantial debt obligations to equity materially improving the Company’s balance sheet. The Company has signed a definitive agreement for the acquisition of Purely Optimal Nutrition, which is expected to add additional revenue and EBITDA. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Forward-Looking Statements

This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer

The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact

Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Staff

Recent Posts

uMed’s AccessCMD next-generation Cardiometabolic Cohort hits 2000 patient milestone in less than 4 months

Providing researchers with unparalleled opportunity to access novel endpoints LONDON, July 10, 2024 /PRNewswire/ -- Healthcare…

1 hour ago

New research from Dräger Safety : 94% think that Health and Safety legislation needs ‘overhauling’

BLYTH, England, July 10, 2024 /PRNewswire/ --  On the fiftieth anniversary of the main piece…

1 hour ago

Poolbeg Pharma PLC Announces Notification of Major Holdings

LONDON, UNITED KINGDOM / ACCESSWIRE / July 10, 2024 / TR-1: Standard form for notification…

4 hours ago

Evotec and Pfizer Collaborate to Advance Drug Discovery in France

Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases HAMBURG,…

4 hours ago

IRLAB Publishes Interim Report for the Period January-June 2024

GOTHENBURG, SWEDEN / ACCESSWIRE / July 10, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July…

4 hours ago

AvodahMed Names Paul Wiley as President

WESTLAKE, Texas, July 9, 2024 /PRNewswire/ -- AvodahMed is pleased to announce the appointment of…

7 hours ago